Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | histone lysine-specific demethylase | 0.0048 | 0.0494 | 1 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0048 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.3809 | 0.3809 |
Loa Loa (eye worm) | hypothetical protein | 0.0255 | 0.4161 | 0.4161 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0048 | 0.0494 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0048 | 0.0494 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0048 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0068 | 0.0846 | 0.0845 |
Brugia malayi | hypothetical protein | 0.0048 | 0.0494 | 0.0508 |
Mycobacterium ulcerans | dehydrogenase | 0.0048 | 0.0494 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.002 | 0 | 0.5 |
Giardia lamblia | hypothetical protein | 0.002 | 0 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0048 | 0.0494 | 0.5 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0048 | 0.0494 | 0.5 |
Brugia malayi | SWIRM domain containing protein | 0.0255 | 0.4161 | 0.4287 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0494 | 0.0493 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0048 | 0.0494 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0048 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.002 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0569 | 0.9706 | 0.9706 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0048 | 0.0494 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0048 | 0.0494 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0048 | 0.0494 | 0.1295 |
Plasmodium vivax | hypothetical protein, conserved | 0.0048 | 0.0494 | 0.5 |
Onchocerca volvulus | CoRest homolog | 0.0586 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.002 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0048 | 0.0494 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0048 | 0.0494 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0048 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0235 | 0.3809 | 0.3809 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0048 | 0.0494 | 0.5 |
Entamoeba histolytica | SWIRM domain protein | 0.002 | 0 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0235 | 0.3809 | 1 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0048 | 0.0494 | 0.1295 |
Trichomonas vaginalis | conserved hypothetical protein | 0.002 | 0 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0048 | 0.0494 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0048 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0048 | 0.0494 | 0.1295 |
Schistosoma mansoni | amine oxidase | 0.0048 | 0.0494 | 0.1295 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0235 | 0.3809 | 1 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0048 | 0.0494 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0048 | 0.0494 | 0.5 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0048 | 0.0494 | 0.1295 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0494 | 0.0493 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0068 | 0.0846 | 0.0871 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.0569 | 0.9706 | 1 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0235 | 0.3809 | 1 |
Echinococcus multilocularis | 0.0048 | 0.0494 | 0.1295 | |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0048 | 0.0494 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.